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Abstract: Background: Antivenom is the definitive treatment for venomous snakebites, but is
expensive and not available in many rural and poorly developed regions. Timely transportation
to facilities that stock and administer antivenom may not be available in rural areas with poorly
developed emergency medical services. These factors have led to consideration of measures to
delay onset of toxicity or alternatives to antivenom therapy. Methods: PubMed searches were
conducted for articles on snakebite treatment, or that contained first aid, emergency medical services,
tourniquets, pressure immobilization bandages, suction devices, and lymphatic flow inhibitors.
Results: The reviewed articles describe how venoms spread after a venomous snakebite on an
extremity, list the proposed first aid measures for delaying the spread of venoms, and evaluate the
scientific studies that support or refute methods of snakebite first aid. The recommendations for
field treatment of venomous snakebites will be discussed. Conclusions: The evidence suggests that
pressure immobilization bandages and related strategies are the best interventions to delay onset of
systemic toxicity from venomous snakebites but may increase local toxicity for venoms that destroy
tissue at the site of the bite, so their use should be individualized to the circumstances and nature of
the venom.
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1. Introduction
Intravenous antivenom is the definitive treatment for venomous snakebites but is expensive,
often in short supply, and not available in many rural and poorly developed regions [1,2].
Timely transportation to facilities that stock and administer antivenom may not be available in
areas with poorly developed emergency medical services. These factors have led to consideration of
measures to delay onset of toxicity or alternatives to antivenom therapy.
This review will describe how venoms spread after a venomous snakebite on an extremity, list the
proposed first aid measures for delaying spread of venoms, and evaluate the scientific studies that
support or refute methods of snakebite first aid. The recommendations for field treatment of poisonous
snakebites will be discussed.
2. Methods
PubMed searches were conducted for articles on snakebite treatment, or that contained first aid,
emergency medical services, tourniquets, pressure immobilization bandages, suction devices, and
lymphatic flow inhibitors. The search encompassed articles from 1945 to 2017. This review emphasizes
articles that initially proposed a technique and recent experimental studies that support or refute
the technique.
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2.1. Systemic Spread of Venom
A venomous snake can inject venom into subcutaneous tissues, muscle, a vein, or an artery.
Intravascular injections result in rapid onset of systemic toxicity [3,4] and can be difficult to treat,
even when antivenom is readily available. No first aid measure, other than supportive care and
advanced life support, will be of benefit in intravascular venom injections.
In a classic study published in 1941, Barnes and Trueta [5] proved that lymphatic flow from
an extremity is the main route via which venoms spread from a subcutaneous extremity injection,
but demonstrated that systemic arrival of venom is delayed by lymphatic ligation. Rabbits were
injected in a hind leg with a fatal dose of tiger snake (Notechis scutatus) venom—a potent neurotoxin.
The treatment group had the groin lymphatic channels ligated. The endpoint was time to death from
respiratory paralysis. Rabbits in the control group expired after an average time of ten minutes, while
those with lymphatic channel ligation survived an hour. This historic study established that flow
through the lymphatic channels was the major route for venoms to reach the systemic circulation.
Further, the study suggested that methods to block lymphatic flow can be effective for delaying onset
of toxicity.
There are four known mechanisms to propel lymph from an extremity to the systemic circulation.
(a) Large lymphatic vessels have smooth muscles in their walls that contract, which is the primary
mode of lymph propulsion in an extremity at rest, suggesting pharmacologic blockade of the intrinsic
lymph pump can retard venom transport. (b) Contraction of skeletal muscles can also propel lymph
to the central circulation, which suggests that immobilization of an extremity can retard lymph flow.
(c) Lymph channels, like veins, have one-way valves that prevent backflow of lymph. (d) Another set
of valves, the contractile valves of lymph endothelial cells, also prevent backward flow of lymph [6].
2.2. Tourniquets
Tourniquets are constricting bands that block arterial, venous, and lymphatic flow. Tourniquets
are often used as first aid after snake envenomation, especially in rural areas where transport times to
a healthcare facility are increased. There are significant complications from their use, which can result
in worsening morbidity and mortality.
A prospective study in the Philippines of 36 hospitalized patients who developed neurotoxic
symptoms after bites from Naja naja philippinensis reported 4 patients who developed complete
respiratory paralysis requiring mechanical ventilation after removal of a tourniquet [7]. From these
findings, the authors recommended slowly releasing already-applied tourniquets. Amaral et al.,
found no difference in plasma creatine kinase enzyme activity, partial thromboplastic time,
plasma whole venom, crotoxin concentrations, and frequency of acute renal and respiratory failure,
or deaths between those who applied a tourniquet and those who did not, after Crotalus durissus
envenomation [8].
A prospective study in Nigeria revealed that patients who received any form of first aid had a
longer length of stay compared to those who received no form of first aid, and that those who had used
a tourniquet had a larger antivenom requirement [9]. One case report of death after the application
of a tourniquet for 48 h occurred; the patient suffered from thrombophlebitis, local necrosis, and gas
gangrene, followed by pulmonary thromboembolism [10].
The lymphatic system transports venom from the envenomation site to systemic circulation.
Application of a tourniquet will sequester venom locally, potentially leading to increased local tissue
destruction when the venom is from those snakes that cause local tissue damage. Additionally,
tourniquets can impede venous blood flow and arterial blood flow, leading to limb ischemia, gangrene,
and potentially amputation.
Guidelines do not support the use of tourniquets. According to World Health Organization
recommendations, arterial tourniquets are contraindicated; their effectiveness relies on occlusion
of peripheral pulses causing pain, ischemia, nerve injury, and gangrenous limbs (level of evidence:
expert opinion/consensus) [1,2]. Deleterious effects from tourniquets are seen within 20 min to 2 h of
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application. The Wilderness Medical Society does not recommend tourniquets for envenomations by
pit vipers in North America [11].
2.3. Venom Extractors
Venom extractors are suction devices that are proposed to work by applying suction to the site of
a snakebite. These devices are marketed by companies that target outdoorsmen. The purported design
is supposed to apply negative pressure over fang marks to induce venom extraction. Venom extractors
can still be purchased through major retailors online and instores, despite several studies proving
their ineffectiveness [12,13]. A human study by Alberts et al., modeling western diamondback
envenomation, demonstrated only a mean 2.0% decrease in total body venom load and an average
0.04% decrease of mock venom at the site of envenomation after 15 min of extraction. A porcine model
with Crotalus atrox venom, by Bush et al., demonstrated concerns for injury by the extraction device
and no benefit in decreasing local tissue injury after 30 min of extraction [13]. Alberts et al. suggested
that the extractors could have collapsed the subcutaneous tissue, and pulled fluid from superficial
capillaries that contain minimal venom load [12]. Our opinion is that any significant change in clinical
outcomes is doubtful with such minute changes in venom load.
Proponents of extractors may counter with the difficulty in replicating a true envenomation with
simulated venom or in an animal model. Single puncture sites instead of two puncture sites were
used in the human study to decrease harm to patients, which is a less common presentation of snake
envenomation [12]. Other variables that are difficult to replicate in human studies are the specific
venom components, and the mechanism of action varies among species of snakes. Also, the volume of
venom typically increases with the size of the snake.
At the time of this review, there are two abstracts that support the suction device, but neither has
been peer reviewed and they include only limited descriptions of methodology. A rabbit study using
the Sawyer Extractor® to retrieve radiolabeled iodine-125 southern Pacific rattlesnake (Crotalus viridis
helleri) venom reportedly removed 23% of the venom within the first 3 min, and 34% after 30 min of
extraction [14]. The second abstract assessed the use of the Sawyer Extractor® pump in 3 individuals
envenomated by western diamondback rattlesnakes (Crotalus atrox) [15]. The volume of fluid extracted
from the victims’ wounds after the initial application of the extractor did not yield a significant
concentration to reduce toxicity. This small amount extracted is unlikely to be of clinical significance.
There are risks with use of these devices: local tissue destruction and a false sense of security.
Bush et al. noted necrosis of tissue with resultant tissue loss in two animals treated with extraction,
which was not seen in untreated animals [13]. Some have alleged that manufacturer claims provide
a ‘false sense of security,’ and may delay a patient from seeking definitive and effective care [16].
Instructional inserts on the Sawyer Products B4 Extractor Pump Kit® (Sawyer Products, Safety Harbor,
FL, USA) do provide a warning that ‘The pump is not a replacement for quickly seeking professional
medical treatment.’
Current guidelines from the Wilderness Medical Society and American Heart Association do
not support the use of mechanical suction for pit viper envenomations [7,17]. An initial search of
the medical literature did not yield results addressing the use of suction for other types of snake
envenomations, such as elapids. Despite the evidence against use of mechanical suction, there are
many unreliable sources available to the public. One study found that of 48 websites reviewed for
accuracy of information regarding pre-hospital care of snakebites, 26 (54.1%) contained inappropriate
recommendations [18]. Education for clinicians and the public regarding safe and effective pre-hospital
care is imperative in preventing further harm to snakebite victims.
2.4. Electric Shock
Electric shock has been advocated as a treatment for venomous snakebites, though there is no
scientific rationale for use of electric shock and no data to support its use, other than case reports. Its use
was advocated in a letter to the editor of Lancet in 1986, in which it was claimed that the experience
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in the jungles of Ecuador of applying a high-voltage, low-amperage electric current to the grounded
extremity prevented both local and systemic toxicity [19]. Electric shocks have been administered from
outboard motors and stun guns. It was ineffective in a controlled study of mice injected with northern
Pacific rattlesnake (Crotalus virldis oreganus) venom at varying doses [20]. The shocks neither reduced
toxicity in rats injected with sublethal doses of fer-de-lance (Bothrops atrox) venom nor lethality in
mice injected with lethal doses [21]. In a case report, administration of electric shock resulted in coma
and incontinence [22]. The United States Food and Drug Administration has banned the use of these
devices, which were previously sold to the public for the treatment of snakebites and spider bites
(United States of America vs. CONO).
2.5. Pressure Immobilization Bandages
The pressure immobilization bandage consists of an ace wrap and splint and is known as the
Commonwealth Serum Laboratories Method. A properly applied ace wrap is sufficient pressure to
block lymphatic flow to an extremity while preserving arterial and venous flow. The splint prevents
muscle contraction that squeezes lymph toward the central circulation. The result is to sequester
venom in the extremity, which is reasonably expected to delay systemic toxicity. For venoms that cause
local necrosis, local damage at the bite site could increase while necrosis could spread away from the
bite site.
A study published in 1974 [23] injected monkeys with tiger snake (Notechis scutatus) venom
and monitored plasma venom levels by radioimmunoassay. Treatment was immobilization of the
extremity with a splint and the application of a firm crepe bandage to the length of the extremity.
This intervention resulted in low levels of circulating venom relative to controls. Neither application
of a splint alone nor of the pressure bandage alone delayed systemic detection of venom.
A controlled study of pressure immobilization bandages (Figure 1) in anesthetized pigs injected
with eastern coral snake (Micrurus fulvius fulvius) venom had an endpoint of survival to eight hours
and used histological analysis of biopsies of the injection site [24]. Four of five subjects in the treatment
group survived to 8 h, while no control group subjects survived. Mean time to onset of respiratory
compromise was 170.4 ± 33.3 min in the control group (Figure 2). None of the pigs had histologic
changes at the envenomation site consistent with ischemia or necrosis.
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control group expired between 191 and 305 min. All subjects in the treatment group survived the 24 h
period. Antivenom was administered to the subjects in the treatment group prior to removal of the
bandage; however, one subject expired after the bandage was removed with hyperkalemia, most likely
from cell necrosis from the venom. While local necrosis did occur and required treatment with analgesia
and antibiotics, subjects who survived were walking on the extremity 7 days after envenomation.
2.6. Compression Pad and Ring
A compression pad, also known as the Monash Method, consists of a pad placed over the site of
envenomation and held in place with a nonelastic band with a pressure of at least 70 mm Hg, combined
with a splint to immobilize the extremity. This method was tested in humans with a radiolabeled mock
venom with comparisons to an air splint and a pressure immobilization bandage [28]. The air splint
and pressure immobilization bandage were used with pressure adjusted to 55 mm Hg. Mock venom
was measured in the serum. Venom in the serum was only retarded relative to controls by the pressure
pad at 70 mm Hg. Whether or not this difference was due to the difference in devices or the increased
pressure used for the compression pad is not known.
A prospective study using the compression pad was conducted in 15 subjects bitten by the
Russell’s viper (Daboia russelii siamensis) in Myanmar. Serum venom levels were monitored after the
application of a rubber pad placed over the bite site and attached with cotton bandages. The rubber
pad measured 65 × 65 × 25 mm and the cotton bandage measured 65 mm × 1.6 m, except for bites
over the fingers and toes, for which measurements were 55 × 30 × 25 mm and 55 × 250 mm for the
pad and bandage, respectively. Proof that the pad retarded venom reaching the central circulation
was demonstrated because venom levels remained constant in 15 of 23 subjects from the time the pad
was placed until the pad was removed. After the pad was removed, venom levels increased by 10 to
40 ng/mL. In the remaining 7 subjects, serum venom levels became undetectable while undergoing
the pad treatment [29].
Since pressure immobilization bandages could not be used for bites on the torso, consideration
was given to a circumferential compression device consisting of a ring with two hooks for attaching a
band to apply pressure (Figure 3). This device was tested in the porcine model for experimental torso
envenomations for both eastern coral snake (Micrurus fulvius fulvius) [30] and eastern diamondback
rattlesnake [31].
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The device consists of a ring with two hooks to attach an elastic belt. The dimensions were
8 × 5 × 3 cm. It was secured with an elastic belt wrapped around the animal. For the coral snake
study, a subcutaneous injection of a 10 mg lethal dose was injected in the torso. Endpoint was survival
to 8 h. Five of the six pigs in the treatment group survived 8 h, with one pig expiring after 293 min.
The three pigs in the control group developed respiratory failure at 322 min (range 272 to 382 min).
The result was significant, with Fisher’s exact test value of 0.04.
In the test of the compression ring device for the eastern diamondback rattlesnake experimental
envenomation to the torso in the porcine model, 50 mg of lyophilized venom reconstituted in sterile
water was injected subcutaneously in sedated subjects allowed to breathe spontaneously. Subjects were
monitored for cardiovascular collapse, fatal arrhythmia, loss of mean arterial pressure or pulse,
or respiratory arrest. Subjects in the treatment group had mean a time to toxicity of 355 ± 65 min
compared with a time of 32 ± 3.5 min in the control group, a result that was significant using a paired
t-test (with p < 0.03).
A study of pressure immobilization for intramuscular injections in a porcine model of
western diamondback rattlesnake (Crotalus atrox) envenomation found that pressure immobilization
prolonged survival and produced less edema than that observed in control animals, but increased
intracompartment pressures relative to in control animals without pressure immobilization [32].
2.7. Lymphatic Flow Inhibitors
Lymphatic flow inhibitors are pharmaceuticals that function by releasing nitric oxide, a compound
that inhibits the intrinsic lymphatic pump. Hence, nitric oxide releasing agents have been considered
as treatment to delay toxicity from venomous snakebites. Once such agent, glyceryl trinitrate ointment
(GTNO), has been studied as a topical agent in both humans and rats injected with mock venom. GTNO
(0.2% weight/weight) is commercially available (Rectogesic, Care Pharmaceuticals, Bondi Junction,
Australia). Human volunteers (6 male, 9 females, age range 20 to 65 years) were injected in the feet
with 50 microliters of sterile radiolabeled colloid. A crossover design was used, with each subject
having venom injected with and without treatment. Foot to groin transit time of the mock venom time
increased from 13 min (range 4 to 81 min) in the controls to 54 min (range 6.5 to 162 min) with treatment.
The result was reported as highly significant with p < 0.0001 (statistical method not specified [33]).
The treatment was also studied in anesthetized rats injected in the hind foot with eastern brown
snake venom (Pseudonaja textilits). The experiment demonstrated that smearing the entire extremity
with GTNO increased the time to respiratory arrest from 65 ± 4 min in control rats to 96 ± 6 min in
GTNO-treated rats (p < 0.001; log-rank test) [33].
2.8. Trypsin Injection
Trypsin is a proteolytic enzyme that has the potential to degrade protein toxins. The proposed
mechanism of action is to digest protein venoms. A randomized, blinded study in anesthetized pigs
was conducted [34]. One minute after injection in a distal hind limb of 10 mg of eastern coral snake
venom (Micrurus fulvius fulvius) dissolved in 1 mL of water, subjects were randomized to receive either
1 mL of saline or 1 mL of trypsin (100 mg/mL) at the envenomation site by a blinded investigator.
Endpoint was survival to 3 days. Respiratory depression occurred more frequently in control subjects
than in those that received trypsin (p = 0.009; Fisher’s exact test). Four of the six pigs that received
trypsin survived to the end of the 3-day study while no control pigs survived. Trypsin is inexpensive
and readily available and would most likely be used for highly potent protein venoms, but further
study is needed before trypsin could be recommended for general use.
2.9. Herbal Medicines
Medicinal plants are used to treat snakebites. A large volume of literature exists on the topic that
is too large to review in this article. A recent review focused on their use in Central America [35] and
concluded that ‘available pharmacological data suggest different plant species may target different
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symptoms of snakebites, such as pain or anxiety, although more studies are needed to further evaluate
the scientific basis for their use.’ A study in Brazil [36] found that extracts of the plant Jatropha mollissima
(Euphorbiaceae), used in folk medicine, had efficacy in reducing local effects from snakebites by the
Bothrops genus that cause the majority of snakebites in Brazil, and suggested that it be used as an
adjuvant to antivenom, which the authors report is less effective in reducing local effects than systemic
effects. A study in a mouse model of Bothrops envenomation found that the plant Costus spicatus,
used in folk medicine as an anti-inflammatory medication, reduced pain and inflammation [37].
Euphorbia hirta was found to reduce lethality in a mouse model of Indian cobra (Naja naja) experimental
snakebites, and the compound quercetin-3-O-alpha-rhamnoside extracted from the plant was found to
have activity against the venom [38]. These and many other studies suggest that traditional medicinal
plants reduce pain and suffering from snakebites and, in specific cases, may prevent lethality. Further
study in this area could lead to specific pharmaceuticals targeted to species against which they have
activity, though development in this area is expensive and unlikely to be widely funded.
2.10. Position Statements
According to the World Health Organization Guidelines for the Management of Snake-Bites [1],
Most of the familiar methods for first-aid treatment of snake-bite, both western and
‘traditional/herbal’, have been found to result in more harm (risk) than good (benefit).
Their use should be discouraged and they should never be allowed to delay the movement
of the patient to medical care at the hospital or dispensary. Recommended first-aid methods
emphasize reassurance, immobilization of the whole patient and particularly the bitten
limb and movement of the patient to a place where they can receive medical care as soon
as possible.
A joint position statement by the American College of Medical Toxicology, American Academy of
Clinical Toxicology, American Association of Poison Control Centers, European Association of Poison
Centers and Clinical Toxicology, International Society of Toxonology, and the Asian Pacific Association
of Medical Toxicology concluded [39],
Given that the primary toxic effect of envenomation is local tissue injury, mortality is not an ideal
outcome measure to extrapolate to human crotaline envenomation. Available evidence fails to
establish the efficacy of pressure immobilization in humans, but does indicate the possibility
of serious adverse events arising from its use. The use of pressure immobilization for the
pre-hospital treatment of North American Crotalinae envenomation is not recommended.
The American Heart Association first aid manual (combined 2010 and 2015 recommendations)
states that the use of pressure immobilization bandages for venomous snakebites be considered,
stating [17],
Applying a pressure immobilization bandage with a pressure between 40 and 70 mm Hg in
the upper extremity and between 55 and 70 mm Hg in the lower extremity around the entire
length of the bitten extremity is a reasonable way to slow the spread of venom by slowing
lymph flow.
For practical purposes pressure is sufficient if the bandage is comfortably tight and snug
but allows a finger to be slipped under it. Initially it was theorized that slowing lymphatic
flow by external pressure would only benefit victims bitten by snakes producing neurotoxic
venom, but the effectiveness of pressure immobilization has also been demonstrated for
bites by non-neurotoxic American snakes in an animal model. The challenge is to find a
way to teach the application of the correct snugness of the bandage because inadequate
pressure is ineffective and too much pressure may cause local tissue damage. It has also been
demonstrated that, once learned, retention of the skill of proper pressure and immobilization
application is poor.
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In Australia, where there are neurotoxic elapid snakes, the recommendation for snakebite first aid
is pressure immobilization bandages [40]:
The first aid for a suspected or definite snake bite is a pressure bandage with immobilization
(PBI). The pressure bandage should be a broad (15 cm) elastic bandage, rather than a crepe
bandage. The bandage is applied over the bite site and then distally to proximally covering
the whole limb. It should be applied about as tight as that used for a sprained ankle. The limb
and whole patient should be immobilized for the first aid to be effective. The bandage and
immobilization should remain until the patient has been transferred and assessed in hospital.
The bandage should only be removed if antivenom is available and after there is no evidence
of envenoming based on the admission laboratory tests and clinical examination. If the
patient is envenomed the bandage can be removed after antivenom has been administered.
3. Conclusions
Antivenom is the definitive treatment for venomous snakebites and should be administered
as soon as possible after a bite. First aid measures should be directed at reducing systemic toxicity
by limiting lymphatic flow. Splints, rest, and avoidance of movement should reduce movement of
the involved extremity. Positioning of the extremity below or at the level of the heart should be
individualized—for snakebites with severe and potentially fatal systemic toxicity, systemic toxicity
might be delayed by positioning the extremity below the heart, while for snakebites with severe local
tissue damage and less systemic toxicity, positioning the extremity below the heart could increase
local toxicity.
Pressure immobilization bandages, compression pads, and compression rings have been shown
in experimental studies to delay systemic absorption of venom and to reduce mortality in some
models. Limited human data supports their use in specific circumstances. They have not been as
effective in field use relative to the laboratory settings because bandages have been applied too loosely,
have not been applied to the entire extremity, and use of a splint has been inconsistent [41]. In a
simulated setting, neither health professionals nor members of the general public performed well in
applying pressure immobilization bandages [42]. The materials necessary for applying this and other
techniques may not be readily available in many circumstances. Their use should be individualized to
the circumstances of the bite, including region, species, timeliness of definitive treatment, and local
guidelines. They are expected to be most helpful in snakebites with lethal systemic toxicity, limited
local toxicity, and a long delay to definitive treatment with antivenom.
Pharmacological treatment with the topical nitric oxide inhibitor GTNO and injection of trypsin
delayed toxicity in experimental studies but need further study. At this time, it is not possible to
give a recommendation for the use of GTNO. Injection of trypsin at the site of the bite has likewise
been efficacious in the treatment of eastern coral snake envenomations in an experimental study but
is not sufficiently developed to recommend its use at this time. Plant extracts used in traditional
medicine have been shown to help with pain and inflammation, and in certain cases to reduce lethality
in experimental studies, and can be considered in rural areas in which folk remedies are available, but
not antivenom.
Injection of trypsin at the site of envenomation had efficacy in one experimental study in a
porcine model and could conceivably play a role in selected situations. However, this approach needs
further investigation.
A number of treatments are generally not recommended. Tourniquets cause limb ischemia
and amputations. Electric shock is dangerous in experimental studies and is not recommended.
Suction devices have no efficacy in experimental studies and cannot be recommended.
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